Evidence map›Paper›PMID 37637579›Full record

ReviewCureus2023

Healthcare Cost and Outcomes Associated With Surgical Site Infection and Patient Outcomes in Low- and Middle-Income Countries.

Fernando Costabella, Keval B Patel, Adedimeji V Adepoju, Purnima Singh, Hussein Attia Hussein Mahmoud, Awais Zafar, Tirath Patel, Ninad A Watekar, Navya Mallesh, Moiz Fawad and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fernando CostabellaDepartment of Pediatrics, Hospital General Dr. Manuel Gea Gonzalez, Mexico City, MEX.
Keval B PatelDepartment of Surgery, Narendra Modi Medical College, Ahmedabad, IND.
Adedimeji V AdepojuDepartment of Surgery, St. George's University, West Indies, GRD.
Purnima SinghCollege of Medicine, Gulf Medical University, Ajman, ARE.
Hussein Attia Hussein MahmoudDepartment of Diagnostic Radiology, Heliopolis Hospital, Cairo, EGY.
Awais ZafarDepartment of Psychiatry, Sahiwal Medical College, Sahiwal, PAK.
Tirath PatelDepartment of Surgery, American University of Antigua, St. John, ATG.
Ninad A WatekarDepartment of Surgery, Davao Medical School Foundation, Davao, PHL.
Navya MalleshDepartment of Surgery, St. Martinus University, Willemstad, CUW.
Moiz FawadDepartment of Neurological Surgery, King Saud Hospital, Unaizah, SAU.
Dily T SathyarajanDepartment of Pediatric Surgery, Indira Gandhi Institute of Child Health, Bengaluru, IND.
Kiran AbbasDepartment of Community Health Sciences, Aga Khan University, Karachi, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical site infection (SSI) is a growing global concern. The principal explanation for this is its adverse clinical outcomes, such as morbidity and mortality. However, the link between the economic burden of SSIs and patient outcomes needs to be sufficiently characterized. This review aims to describe the financial implications of SSIs on patient outcomes in low- and middle-income countries (LMIC). Despite the heterogeneity in study designs from multiple LMIC countries, there is a significant correlation between SSI-associated healthcare costs from increased length of stay (LOS), readmissions, reoperations, and adverse patient outcomes. This varies based on the size, degree of infection, or other patient comorbidities. SSIs are much more prevalent in LMICs. The additional financial burden incurred in managing SSIs reinforces the need to prioritize practicing interventions to prevent this complication, which resource-limited health institutions are unequipped to do and consequently have significant adverse patient outcomes.

Indexed as

economic burden of healthcarefinancial impacthealthcare costsscarce resource allocationsurgical site infections (ssi)

Identifiers

PMID37637579
PMCPMC10455046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.